Below are brief introductions to HPV disease and the HPV vaccine with links to more information. Scroll down for a list of QUICK FACTS that provide a summary overview of key facts for the disease and the vaccine.
Human papillomavirus (HPV) is the most commonly sexually transmitted infection in the U.S. There are more than 200 known types of HPV and about 75 percent of these types are considered not harmful.12 The most common high-risk cancer-causing HPV types are 16 and 18.3 There are six HPV-related cancers; cervical, oral (oropharyngeal), vaginal, penile, anal, and vulvar.45
Most sexually active women and men become infected with HPV, with the majority of cases recovering from infection without symptoms or complications6 and more than 90 percent of cases recover within two years.78 Natural recovery provides HPV type specific antibodies within the individual’s body to help prevent future infections; however, the protection may not be life-long.9
The American Cancer Society estimates in 2023 that out of an estimated total U.S. population of 334 million individuals a total of just over 30,000 (.009 percent) HPV-related cancer cases will occur and result in under 8,000 (.002 percent) deaths for HPV types targeted by Gardasil 9 vaccine.101112131415
While there are three FDA licensed HPV vaccines, only Gardasil 9 by Merck is currently available in the U.S. The CDC’s current recommendation is a two-dose series16 for ages 15 through 26 years, and those with immunocompromising conditions.17 Gardasil 9 by Merck was licensed to prevent HPV-related cervical, vulvar and anal cancers, genital warts, and precancerous lesions. According to the CDC, the effectiveness of HPV vaccination is still unknown and “it may take decades to see population-level impact” from HPV vaccine.18
Though public health officials acknowledge there is minimal benefit in adult HPV vaccination, the vaccine is available to adults 26 through 45 years.19 For females over 21 years of age, HPV vaccination does not replace the need for routine Pap smear testing to detect abnormal cells that can cause cervical cancer especially considering that cervical cancer can be caused by HPV types not included in the vaccine.20